Table 2 Glycan array results for CTL4 and CTLMA2*.

From: Solution structure, glycan specificity and of phenol oxidase inhibitory activity of Anopheles C-type lectins CTL4 and CTLMA2

ID#

Glycans

CTL4

CTLMA2

CTL4/CTLMA2

6

GalNAcβ-sp3

  

1.14

47

6-H2PO3Manα-sp3

  

1.32

113

GlcNAcβ1-3GalNAcα-sp3

  

1.16

163

6-O-Su-Galβ1-4GlcNAcβ-sp3

1.96

  

199

4,6-O-Su2-GalNAcβ1-4-(3-O-Ac)GlcNAcβ-sp3

 

1.42

 

251

GlcNAcβ1-4Galβ1-4GlcNAcβ-sp2

 

1.04

 

287

3-O-Su-Galβ1-3(Fucα1-4)GlcNAcβ-sp3

 

1.12

1.14

368

Fucα1-2(GalNAcα1-3)Galβ1-4GlcNAcβ-sp3

  

1.42

383

Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-sp2

  

1.47

421

Neu5Acα2-3(GalNAcβ1-4)Galβ1-4Glcβ-sp2

  

1.94

428

Fucα1-3(Neu5Acα2-3Galβ1-4)6-O-Su-GlcNAcβ-sp3

 

1.01

1.38

479

Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-sp4

  

1.92

488

Galβ1-4GlcNAcβ1-3(Galβ1-4GlcNAcβ1-6)GalNAcα-sp3

 

1

1.53

505

(GN-M)2-3,6-M-GN-GNβ-sp4

 

1.18

1.74

529

Neu5Acα2-6(Galβ1-3)GlcNAcβ1-3Galβ1-4Glcβ-sp4

 

1.09

1.49

533

(Neu5Acα2-8)2Neu5Acα2-3(GalNAcβ1-4)Galβ1-4Glc-sp2

  

1.58

536

Neu5Acα2-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-sp4

  

2.13

625

(GlcAβ1-4GlcNAcβ1-3)8-NH2-ol

  

2.14

18B

Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glc

3.65

  

13 K

(GlcA/IdoAβ1-3(±4/6S)GalNAcβ1-4)n (n < 250)

  

2.16

13 M

(GlcA/IdoAβ1-3(±6S) GalNAcβ1-4)n (n < 250)

  

2.94

14I

HA 1600000 da 2.5 mg/ml

1.48

 

1.52

14 K

β1-3Glucan

2.32

  
  1. *Values indicate fold above background plus three standard errors of the background (average of four technical replicates). Abbreviations: GN – GalNac; HA – haemagglutinin; M – mannose.